amytrx / Amytrx Therapeutics

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.amytrx.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Amytrx Therapeutics
Description	The Next Generation of Amytrx Therapeutics is a clinical-stage biopharmaceutical company developing novel peptide therapies for the treatment of inflammatory
Keywords	N/A

Server Information

WebSite	amytrx.com
Host IP	185.230.63.107
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

amytrx.com Valuation

US$2,458,494

Last updated: 2023-05-07 10:03:53

amytrx.com has Semrush global rank of 4,305,198. amytrx.com has an estimated worth of US$ 2,458,494, based on its estimated Ads revenue. amytrx.com receives approximately 283,673 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, amytrx.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,458,494
Daily Ads Revenue	US$2,270
Monthly Ads Revenue	US$68,082
Yearly Ads Revenue	US$816,977
Daily Unique Visitors	18,912
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
amytrx.com.	A	3599	IP: 185.230.63.107
amytrx.com.	A	3599	IP: 185.230.63.171
amytrx.com.	A	3599	IP: 185.230.63.186
amytrx.com.	NS	86400	NS Record: ns7.wixdns.net.
amytrx.com.	NS	86400	NS Record: ns6.wixdns.net.
amytrx.com.	MX	3600	MX Record: 40 alt3.aspmx.l.google.com.
amytrx.com.	MX	3600	MX Record: 30 alt2.aspmx.l.google.com.
amytrx.com.	MX	3600	MX Record: 50 alt4.aspmx.l.google.com.
amytrx.com.	MX	3600	MX Record: 20 alt1.aspmx.l.google.com.
amytrx.com.	MX	3600	MX Record: 10 aspmx.l.google.com.

HtmlToTextCheckTime:2023-05-07 10:03:53

top of page About Science Pipeline News Collaboration Contact Introducing AMTX-100 Our cell-penetrating peptide interrupts inflammation intracellularly at its source to improve the lives of patients with immune-mediated diseases. The Next Generation of Medicines Excessive or uncontrolled inflammation is known to be the source of many chronic diseases and aging. Drawing on 30 years of research, Amytrx is harnessing the novel power of cell-penetrating anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases. Our lead therapeutic peptide AMTX-100 is bioengineered from human protein sequences that modulate the immune system by a selective, natural process already used by cells, reducing pathogenesis in a range of conditions. AMTX-100 can bind to and penetrate immune cells to attenuate their intracellular molecular machinery and help ease inflammation early in the process in advance of gene activation. In clinical

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 19:41:50 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.amytrx.com/
strict-transport-security: max-age=120
Age: 2002
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgAmI6NXu6WfqLI/M7f8tcV,m0j2EEknGIVUW/liY8BLLg+F4RAy97FgBhKEMuS3Uv3F+NHRbelhY0dsZwjDYnLI,2d58ifebGbosy5xc+FRalgw4aDraILIn+jgAvY6q0EU24Eq8r6vD3qF8jl/ysHvZfVDWWVdryuuWkq/vyLnRhg==,2UNV7KOq4oGjA5+PKsX47Br+ilU2OUaGN9cE2DqPolkfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635363710.9675115275771415354
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 27 Oct 2021 19:41:51 GMT
content-type: text/html; charset=UTF-8
content-length: 333649
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"882ae2e7b874bdc3318746179340e270"
content-language: en-US
strict-transport-security: max-age=120
age: 9515
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMeJT5JcVPlGT/wCdpQ+vEbD,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalirXJe5npxev29jnUbmz0faPk7zUJtXEVpZ1mSd54UrPXHkAKB7hhcYsJGs4a0DC50sHhB0L0P4bC6qQhDWNGss=,2UNV7KOq4oGjA5+PKsX47IQ1W7HSN3SNDOe/tYFyJmdYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635363711.0955378508194106
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=usc1_g; Max-Age=20; Expires=Wed, 27 Oct 2021 19:42:11 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

amytrx.com Whois Information

Domain Name: AMYTRX.COM
Registry Domain ID: 2055269296_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-12-17T20:59:09Z
Creation Date: 2016-08-26T16:56:01Z
Registry Expiry Date: 2023-08-26T16:56:01Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T15:28:36Z <<<

amytrx.com valuation and analysis